Drugs / THERATOPE STn-KLH
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00003638 | Jan 1999 → Jan 2007 | breast cancer | Oncothyreon Canada Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | THERATOPE STn-KLH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003638 ↗ |
| Modality | Vaccine | “A multicenter, double blinded, randomized phase III trial of the therapeutic cancer vaccine sialy1-Tn (STn) conjugated to keyhole-limpet Hemocyanin (KLH) was completed in an...” PMID 23983823 ↗ Aug 2013 |
| Route | Subcutaneous | “4 subcutaneous vaccinations with THERATOPE STn-KLH vaccine combined with Detox-B Stable Emulsion” NCT00003638 ↗ |